rologie i - European Congress of Virology
rologie i - European Congress of Virology
rologie i - European Congress of Virology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5 th <strong>European</strong> <strong>Congress</strong> <strong>of</strong> <strong>Virology</strong>26. VIRAL INFECTIONS INTRANSPLANT ANDIMMUNOCOMPROMISED PATIENTSPosters: REF 539 to REF 562REF 539Determination <strong>of</strong> anti HCMV T Cell response <strong>of</strong> potential recipientsand donors in cellular immunotherapy <strong>of</strong> leukemic patients aftertransplantation <strong>of</strong> hematopoetic stem cells (SCT)Sarka NEMECKOVA 1 , Katarina BABIAROVA 1 , Jitka KRYSTOFOVA 1 ,Petr HAINZ 1 , Kamila ZURKOVA 1 , Marketa STASTNA MARKOVA 21 Institute <strong>of</strong> Hematology and Blood Transfusion, Department <strong>of</strong> experimentalvirology, Prague, CZECH REPUBLIC; 2 Institute <strong>of</strong> Hematologyand Blood Transfusion, Transplantation Ward, Prague, CZECH REPU-BLICCytomegalovirus (CMV) reactivation in immunosuppressed patients isassociated with morbidity and mortality. The testing CMV specific T cellresponse can help to find the patients which are in a high risk <strong>of</strong> CMVdisease. Such patients would pr<strong>of</strong>it from adoptive transfer <strong>of</strong> CMV specificT cells. Cellular immune response against CMV <strong>of</strong> 14 patients after allogeneicSCT was monitored for 180 days by ELISPOT interferon gammawith the aim to find patients with insufficient control <strong>of</strong> CMV reactivation.The second aim was to compare various forms <strong>of</strong> CMV antigen forin vitro stimulation. The patients after SCT were classified according tothe anti CMV T cell response, the presence <strong>of</strong> CMV DNA in the blood andthe response <strong>of</strong> T cells after stimulation with anti CD3 antibody into fourgroups: 1) CMV DNA (neg.), anti CMV T cells + (pos.); 2) CMV DNA,anti CMV T cells; 3) CMV DNA +, anti CMV T cells, CD3+; 4) CMVDNA +, anti HCMV T cells, CD3. Patients <strong>of</strong> groups 3,4 would benefitfrom adoptive transfer. By testing the recall response <strong>of</strong> T cells <strong>of</strong> donorsagainst pp65, IE 1, US3, UL36, US29, UL55 peptide pools, pp65, IE 1epitopes or CMV lysate we found that inclusion <strong>of</strong> US3, UL36, US29,UL55 as testing antigens can increase significantly the overall response<strong>of</strong> anti CMV T cells. We observed that stimulation with the long 30merpeptides from pp65 or IE 1 sequence induced activation <strong>of</strong> CD8 and CD4antiviral T cells. The long peptides could be used for T cell activation<strong>of</strong> multiple epitopes if the MHCI binding minimal CTL epitopes are notknown.Supported by NT/13898/2012 grant.donor/recipient status (D R). Virus load (VL) was measured by RochePCR. In all 10 D+R patients primary HCMV infection led to a development<strong>of</strong> total and IgG3 HCMV ABs, but 2 patients showed no IgG1 response.Total HCMV IgG, and IgG3 AB RLUs remained stable post TX within 1log during follow up in all 9DR+andD+R+ patients without detectableVL and in 86% and 96% <strong>of</strong> 28 patients with detectable VL, respectively.In contrast, IgG1 subclass ABs were variable in 46% <strong>of</strong> the patients (RLUvariation >1log) who developed HCMV VL. In 7 cases IgG1 declinedprior to viremia and in 6 patients IgG1 increased during virus replication.HCMV total IgG and IgG3 AB responses are stable over time, while IgG1ABs exhibit substantial variability in relation to virus replication. Theclinical implications <strong>of</strong> these data will be further elucidated.REF 541Detection <strong>of</strong> TS polyomavirus from tonsillar tissues <strong>of</strong> children andadultsMohammadreza SADEGHI 1 , Lea HEDMAN 1,2 , Leena MaijaAALTONEN 3 , Maria SÖDERLUND VENERMO 1 , Klaus HEDMAN 1,21 Department <strong>of</strong> <strong>Virology</strong>, Haartman Institute, University <strong>of</strong> Helsinki, Helsinki,FINLAND; 2 Department <strong>of</strong> <strong>Virology</strong> and Immunology, HelsinkiUniversity Central Hospital Laboratory Division, Helsinki, FINLAND;3 Department <strong>of</strong> Otorhinolaryngology Head and Neck Surgery, HelsinkiUniversity Central Hospital, Helsinki, FINLANDBackground: in the past few years several new polyomaviruses <strong>of</strong> humanshave been discovered. Trichodysplasia spinulosa associated polyomavirus(TSPyV) was identified in a patient with trichodysplasia spinulosa (TS), arare follicular skin disease <strong>of</strong> immunocompromised patients. Seroepidemiologicalstudies indicate that TSPyV is ubiquitous and infects ∼ 70% <strong>of</strong>healthy individuals. We have shown that the tonsil may be a site <strong>of</strong> WUPyVinitial infection and <strong>of</strong> MCPyV persistence. Whether TSPyV persistenceoccurs in the lymphoid system is unknown.Methods: to determine whether tonsils harbor TSPyV, we tested a total <strong>of</strong>229 matched pairs <strong>of</strong> tonsillar tissues and sera from asymptomatic childrenor adults (overall mean age 21.0 years). The samples were also screenedfor the single copy human RNase P gene by real time quantitative PCR(qPCR). TSPyV was detected by qPCRs with Taq Man probes and primerpairs targeting the VP1 or LT genes. Results: TSPyV DNA was detectedin 8 <strong>of</strong> 229 (3.5%) tonsillar tissues, from both cohorts, and in none <strong>of</strong>the corresponding sera. Sequence analysis <strong>of</strong> the 8 virus positive samplesconfirmed the identity <strong>of</strong> TSPyV.Conclusions: these data provide the first evidence <strong>of</strong> TSPyV in tonsillartissue and suggest that (i) tonsils may serve as an initial site <strong>of</strong> TS polyomavirusinfection and that (ii) lymphoid tissue may be a persistence sitefor this virus.REF 540Human Cytomegalovirus specific IgG subclass antibody kinetics inthe follow up after lung transplantationBenedikt SIMON, Irene GÖRZER, Elisabeth PUCHHAMMERSTÖCKLDepartment <strong>of</strong> <strong>Virology</strong>, Med Uni Wien, Vienna, AUSTRIAHuman cytomegalovirus (HCMV) may cause severe infections in lungtransplant recipients (LTRs). HCMV specific AB response limits virusreplication, but the kinetics <strong>of</strong> subclass AB response after transplantation(TX) are not clear.We analyzed the HCMV specific IgG AB kinetics <strong>of</strong> total IgG and <strong>of</strong> thedominant IgG AB subclasses 1 and 3 after TX and assessed whether theseare associated with HCMV replication in the follow up. HCMV AB titers <strong>of</strong>53 LTRs were measured repeatedly post TX using the MEDAC CMV IgGELISA, modified for subclass 1 and 3 ABs. ODs were expressed in relativelight units (RLUs). Cut <strong>of</strong>fs were established in patients with HCMVREF 542The Reactivation <strong>of</strong> Immunomodulating Beta Herpesviruses Infectionin Patients Undergoing Microvascular Free Flap SurgeriesArnis VILKS 1,2 , Romans DZALBS 4 , Santa RASA 3 , Zaiga NoraKRUKLE 3 , Viesturs BOKA 1 , Biruta MAMAJA 2,1 , ModraMUROVSKA 31 Riga Eastern Clinical University Hospital Gailezers, Riga, LATVIA;2 Riga Stradins University, Department <strong>of</strong> Anaesthesiology and Reanimatology,Riga, LATVIA; 3 Riga Stradins University, A. Kirchenstein Institute<strong>of</strong> Microbiology and <strong>Virology</strong>, Riga, LATVIA; 4 Riga Stradins University,Faculty <strong>of</strong> Medicine, Riga, LATVIABeta herpesviruses HHV 6 and HHV 7 are immunomodulating viruses.They have the ability to impair host defence system seriously and maycontribute to other infectious pathogens due to immune suppression. Wehave investigated the effect <strong>of</strong> long lasting microvascular free flap surgeryS270 Vi<strong>rologie</strong>, Vol 17, supplément 2, septembre 2013